Tutu Mzee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Tutu Mzee has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
Joseph Madata
Ifakara Health Institute, Bagamoyo, Tanzania
2 shared publicationsMarkus Bischoff
Institute of Medical Microbiology and Hygiene, Saarland University, Homburg, Germany
2 shared publicationsMecky Matee
Department of Microbiology and Immunology, School of Medicine, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania
2 shared publicationsRose Masalu
Department of Molecular Biology and Biotechnology, University of Dar es Salaam, Dar es Salaam, Tanzania
2 shared publications- Tarsis Mlaganile
Ifakara Health Institute, Bagamoyo Branch, Bagamoyo P.O. Box 74, Tanzania
2 shared publications Theckla Kazimoto
Ifakara Health Institute, Bagamoyo, Tanzania
2 shared publications
Latest Publications
- Open Access
- 5 June 2023
- Published by MDPI AG in Microorganisms
- Vol. 11 (6) , 1505
Molecular Characterization of Staphylococcus aureus Isolated from Raw Milk and Humans in Eastern Tanzania: Genetic Diversity and Inter-Host Transmission
Staphylococcus aureus is a common cause of infection in humans and animals, including bovine mastitis, globally. The objective of this study was to genetically characterize a collection of S. aureus isolates recovered from milk and nasal swabs from humans with and without animal contact (bovine = 43, human = 12). Using whole genome sequencing (NextSeq550), isolates were sequence typed, screened for antimicrobial resistance and virulence genes and examined for possible inter-species host transmission. Multi locus sequence typing (MLST) and single nucleotide polymorphism (SNP)-based phylogeny revealed 14 different sequence types, including the following six novel sequence types: ST7840, 7841, 7845, 7846, 7847, and 7848. The SNP tree confirmed that MLST clustering occurred most commonly within CC97, CC5477, and CC152. ResFinder analysis revealed five common antibiotic resistance genes, namely tet(K), blaZ, dfrG, erm©, and str, encoding for different antibiotics. mecA was discovered in one human isolate only. Multidrug resistance was observed in 25% of the isolates, predominantly in CC152 (7/8) and CC121 (3/4). Known bovine S. aureus (CC97) were collected in humans and known human S. aureus lineages (CC152) were collected in cattle; additionally, when these were compared to bovine-isolated CC97 and human-isolated CC152, respectively, no genetic distinction could be observed. This is suggestive of inter-host transmission and supports the need for surveillance of the human–animal interface.
- 5 June 2023
- Published by MDPI AG in Microorganisms
- Vol. 11 (6) , 1505
Open AccessMolecular Characterization of Staphylococcus aureus Isolated from Raw Milk and Humans in Eastern Tanzania: Genetic Diversity and Inter-Host Transmission
Staphylococcus aureus is a common cause of infection in humans and animals, including bovine mastitis, globally. The objective of this study was to genetically characterize a collection of S. aureus isolates recovered from milk and nasal swabs from humans with and without animal contact (bovine = 43, human = 12). Using whole genome sequencing (NextSeq550), isolates were sequence typed, screened for antimicrobial resistance and virulence genes and examined for possible inter-species host transmission. Multi locus sequence typing (MLST) and single nucleotide polymorphism (SNP)-based phylogeny revealed 14 different sequence types, including the following six novel sequence types: ST7840, 7841, 7845, 7846, 7847, and 7848. The SNP tree confirmed that MLST clustering occurred most commonly within CC97, CC5477, and CC152. ResFinder analysis revealed five common antibiotic resistance genes, namely tet(K), blaZ, dfrG, erm©, and str, encoding for different antibiotics. mecA was discovered in one human isolate only. Multidrug resistance was observed in 25% of the isolates, predominantly in CC152 (7/8) and CC121 (3/4). Known bovine S. aureus (CC97) were collected in humans and known human S. aureus lineages (CC152) were collected in cattle; additionally, when these were compared to bovine-isolated CC97 and human-isolated CC152, respectively, no genetic distinction could be observed. This is suggestive of inter-host transmission and supports the need for surveillance of the human–animal interface.
- Open Access
- 12 June 2022
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 7 (6) , 100
Microbiological Characterisation of Community-Acquired Urinary Tract Infections in Bagamoyo, Tanzania: A Prospective Study
Urinary tract infections (UTIs) are among the most common infections in sub-Saharan Africa, but microbiological data to guide treatment decisions are limited. Hence, we investigated the bacterial aetiology and corresponding antimicrobial susceptibility patterns in outpatients with UTIs in Bagamoyo, Tanzania. Urine samples from symptomatic individuals were subjected to microbiological examinations for bacterial species identification using conventional methods and disc diffusion-based resistance testing. Subsequently, urine samples were transferred to Germany for confirmatory diagnostics using matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry and automated resistance testing. Overall, 104 out of 270 (38.5%) individuals had a positive urine culture and 119 putative pathogens were identified. The most frequently detected bacteria were Escherichia coli (23%), Klebsiella spp. (7%), Enterobacter cloacae complex (3%) and Staphylococcus aureus (2%). E. coli isolates showed high resistance against cotrimoxazole (76%), ampicillin (74%), piperacillin (74%) and fluoroquinolones (37%), but widespread susceptibility to meropenem (100%), fosfomycin (98%), piperacillin/tazobactam (97%) and amoxicillin/clavulanic acid (82%). The agreement between E. coli susceptibility testing results in Tanzania and Germany was ≥95%, except for piperacillin/tazobactam (89%) and ciprofloxacin (84%). Given the considerable resistance to frequently prescribed antibiotics, such as cotrimoxazole and fluoroquinolones, future research should explore the potential of oral alternatives (e.g., fosfomycin) for the treatment of UTIs in Tanzania.
- 12 June 2022
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 7 (6) , 100
Open AccessMicrobiological Characterisation of Community-Acquired Urinary Tract Infections in Bagamoyo, Tanzania: A Prospective Study
Urinary tract infections (UTIs) are among the most common infections in sub-Saharan Africa, but microbiological data to guide treatment decisions are limited. Hence, we investigated the bacterial aetiology and corresponding antimicrobial susceptibility patterns in outpatients with UTIs in Bagamoyo, Tanzania. Urine samples from symptomatic individuals were subjected to microbiological examinations for bacterial species identification using conventional methods and disc diffusion-based resistance testing. Subsequently, urine samples were transferred to Germany for confirmatory diagnostics using matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry and automated resistance testing. Overall, 104 out of 270 (38.5%) individuals had a positive urine culture and 119 putative pathogens were identified. The most frequently detected bacteria were Escherichia coli (23%), Klebsiella spp. (7%), Enterobacter cloacae complex (3%) and Staphylococcus aureus (2%). E. coli isolates showed high resistance against cotrimoxazole (76%), ampicillin (74%), piperacillin (74%) and fluoroquinolones (37%), but widespread susceptibility to meropenem (100%), fosfomycin (98%), piperacillin/tazobactam (97%) and amoxicillin/clavulanic acid (82%). The agreement between E. coli susceptibility testing results in Tanzania and Germany was ≥95%, except for piperacillin/tazobactam (89%) and ciprofloxacin (84%). Given the considerable resistance to frequently prescribed antibiotics, such as cotrimoxazole and fluoroquinolones, future research should explore the potential of oral alternatives (e.g., fosfomycin) for the treatment of UTIs in Tanzania.
- Open Access
- 27 September 2021
- Published by Springer Nature in Bulletin of the National Research Centre
- Vol. 45 (1) , 1-21
Prevalence, antimicrobial susceptibility and genotypic characteristics of Staphylococcus aureus in Tanzania: a systematic review
Background: Data on the prevalence, genotypes and antibiotic resistance patterns of colonizing and infection-associatedStaphylococcus aureus(S. aureus) strains both in humans and animals in Tanzania are scarce. Given the wide range of infections caused byS. aureusand the rise of methicillin-resistantS. aureus(MRSA) globally, this review aims at collecting published data onS. aureusbacterium to improve our understanding of its epidemiology in Tanzania.Main body: We carried out a systematic review of scientific studies reporting on prevalence, antibiotic resistance and genotyping data pertaining toS. aureusin human and animal infection and colonization. The literature extracted from electronic databases such as PubMed and Google Scholar was screened for eligibility and relevant articles were included. The review is limited to manuscripts published in English language between the years 2010 and 2020. A total of 45 studies conducted in 7 of the 9 administrative zones in Tanzania were reviewed to gather data onS. aureusprevalence in humans and animals. Prevalence in humans ranged from 1 to 60%. Antibiotic resistance patterns ofS. aureusisolated from colonized humans showed high resistance rates against co-trimoxazole (46%) and erythromycin (41%) as compared to reports from studies conducted outside Africa. The review suggests an increased MRSA prevalence of up to 26% as compared to 6–16% reported in previous years. Genotypic data reviewed suggested that MRSA predominantly belonged to ST88. The prevalence ofS. aureusin animal studies ranged from 33 to 49%, with 4 to 35% of MRSA isolates. Most studies reported low antibiotic resistance levels, with the exception of penicillin (85%) and ampicillin (73%).Conclusion: The prevalence ofS. aureusand MRSA in Tanzania is rising, although clear variations between different geographic areas could be observed. Non-susceptibility to commonly prescribed antibiotics in community-associatedS. aureusis of concern. Research strategies to ameliorate our knowledge onS. aureusepidemiology should employ regular antibiotic resistance surveillance, antimicrobial stewardship as well as genotypic characterization.
- 27 September 2021
- Published by Springer Nature in Bulletin of the National Research Centre
- Vol. 45 (1) , 1-21
Open AccessPrevalence, antimicrobial susceptibility and genotypic characteristics of Staphylococcus aureus in Tanzania: a systematic review
Background: Data on the prevalence, genotypes and antibiotic resistance patterns of colonizing and infection-associatedStaphylococcus aureus(S. aureus) strains both in humans and animals in Tanzania are scarce. Given the wide range of infections caused byS. aureusand the rise of methicillin-resistantS. aureus(MRSA) globally, this review aims at collecting published data onS. aureusbacterium to improve our understanding of its epidemiology in Tanzania.Main body: We carried out a systematic review of scientific studies reporting on prevalence, antibiotic resistance and genotyping data pertaining toS. aureusin human and animal infection and colonization. The literature extracted from electronic databases such as PubMed and Google Scholar was screened for eligibility and relevant articles were included. The review is limited to manuscripts published in English language between the years 2010 and 2020. A total of 45 studies conducted in 7 of the 9 administrative zones in Tanzania were reviewed to gather data onS. aureusprevalence in humans and animals. Prevalence in humans ranged from 1 to 60%. Antibiotic resistance patterns ofS. aureusisolated from colonized humans showed high resistance rates against co-trimoxazole (46%) and erythromycin (41%) as compared to reports from studies conducted outside Africa. The review suggests an increased MRSA prevalence of up to 26% as compared to 6–16% reported in previous years. Genotypic data reviewed suggested that MRSA predominantly belonged to ST88. The prevalence ofS. aureusin animal studies ranged from 33 to 49%, with 4 to 35% of MRSA isolates. Most studies reported low antibiotic resistance levels, with the exception of penicillin (85%) and ampicillin (73%).Conclusion: The prevalence ofS. aureusand MRSA in Tanzania is rising, although clear variations between different geographic areas could be observed. Non-susceptibility to commonly prescribed antibiotics in community-associatedS. aureusis of concern. Research strategies to ameliorate our knowledge onS. aureusepidemiology should employ regular antibiotic resistance surveillance, antimicrobial stewardship as well as genotypic characterization.
- Open Access
- 12 March 2020
- Published by Springer Nature in Research Square
Prevalence, antimicrobial susceptibility and genotypic characteristics of Staphylococcus aureus in Tanzania: a systematic review
Background : Information about prevalence, antibiotic resistance and genotyping data of Staphylococcus aureus (S aureus) isolated from different infections and colonization, both in humans and animals is scarce in Tanzania. Given the wide range of infections S aureus can cause and the raise of methicillin resistant S aureus (MRSA) globally, this review was aimed at collecting local published data on the S aureus bacterium to better understand the epidemiology. Methodology: A systematic review of scientific studies reporting on prevalence, antibiotic resistance and genotyping of S aureus in human and animal infection and colonization was done. Literatures extracted from electronic databases such as PubMed and Google Scholar were screened for eligibility and relevant articles included into the review. The review is limited to literatures published in English, between the years 2010 and 2018. . Results: 39 studies conducted in 5 of the 9 administrative zones in Tanzania were reviewed to establish S aureus prevalence in human and animal infection and colonization. Prevalence in human ranged from 1 - 60%. Antibiotic resistance patterns of S aureus isolated from colonized humans showed higher resistance rates against erythromycin (49%), co-trimoxazole (38%) and tetracycline (28%) compared to report from other studies outside Africa. The review suggests an increased MRSA prevalence of up to 33% compared to 16% reported in previous years. Genotypic data reviewed suggested that MRSA predominantly belonged to ST88. S aureus prevalence in animal studies ranged from 33 - 49% whereas MRSA prevalence ranged from 4 - 35%. Generally low antibiotic resistance levels were reported in these studies with exception to penicillin (85%) and ampicillin (73%). Resistance against tetracycline reported at 30% collaborates the suggested overuse of the drug in livestock keeping in Tanzania. Conclusion : Prevalence of MRSA in Tanzania is rising although clear variations between different geographic areas could be observed. Non-susceptibility to commonly prescribed antibiotics in community associated S aureus is of concern. Research strategies to better understand the S aureus epidemiology by including genotypic characterisations, as well as strengthening antimicrobial resistance surveillance and antimicrobial stewardship are recommended.
- 12 March 2020
- Published by Springer Nature in Research Square
Open AccessPrevalence, antimicrobial susceptibility and genotypic characteristics of Staphylococcus aureus in Tanzania: a systematic review
Background : Information about prevalence, antibiotic resistance and genotyping data of Staphylococcus aureus (S aureus) isolated from different infections and colonization, both in humans and animals is scarce in Tanzania. Given the wide range of infections S aureus can cause and the raise of methicillin resistant S aureus (MRSA) globally, this review was aimed at collecting local published data on the S aureus bacterium to better understand the epidemiology. Methodology: A systematic review of scientific studies reporting on prevalence, antibiotic resistance and genotyping of S aureus in human and animal infection and colonization was done. Literatures extracted from electronic databases such as PubMed and Google Scholar were screened for eligibility and relevant articles included into the review. The review is limited to literatures published in English, between the years 2010 and 2018. . Results: 39 studies conducted in 5 of the 9 administrative zones in Tanzania were reviewed to establish S aureus prevalence in human and animal infection and colonization. Prevalence in human ranged from 1 - 60%. Antibiotic resistance patterns of S aureus isolated from colonized humans showed higher resistance rates against erythromycin (49%), co-trimoxazole (38%) and tetracycline (28%) compared to report from other studies outside Africa. The review suggests an increased MRSA prevalence of up to 33% compared to 16% reported in previous years. Genotypic data reviewed suggested that MRSA predominantly belonged to ST88. S aureus prevalence in animal studies ranged from 33 - 49% whereas MRSA prevalence ranged from 4 - 35%. Generally low antibiotic resistance levels were reported in these studies with exception to penicillin (85%) and ampicillin (73%). Resistance against tetracycline reported at 30% collaborates the suggested overuse of the drug in livestock keeping in Tanzania. Conclusion : Prevalence of MRSA in Tanzania is rising although clear variations between different geographic areas could be observed. Non-susceptibility to commonly prescribed antibiotics in community associated S aureus is of concern. Research strategies to better understand the S aureus epidemiology by including genotypic characterisations, as well as strengthening antimicrobial resistance surveillance and antimicrobial stewardship are recommended.
- Open Access
- 4 March 2013
- Published by Springer Nature in Malaria Journal
- Vol. 12 (1) , 86
Experience and challenges from clinical trials with malaria vaccines in Africa
Malaria vaccines are considered amongst the most important modalities for potential elimination of malaria disease and transmission. Research and development in this field has been an area of intense effort by many groups over the last few decades. Despite this, there is currently no licensed malaria vaccine. Researchers, clinical trialists and vaccine developers have been working on many approached to make malaria vaccine available.
- 4 March 2013
- Published by Springer Nature in Malaria Journal
- Vol. 12 (1) , 86
Open AccessExperience and challenges from clinical trials with malaria vaccines in Africa
Malaria vaccines are considered amongst the most important modalities for potential elimination of malaria disease and transmission. Research and development in this field has been an area of intense effort by many groups over the last few decades. Despite this, there is currently no licensed malaria vaccine. Researchers, clinical trialists and vaccine developers have been working on many approached to make malaria vaccine available.